Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin | 12 | 2023 | 2917 | 1.230 |
Why?
|
Enhancer Elements, Genetic | 6 | 2021 | 1337 | 1.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 21 | 2022 | 8425 | 0.890 |
Why?
|
Transcription Factors | 7 | 2021 | 12164 | 0.670 |
Why?
|
Gene Expression Profiling | 14 | 2022 | 9410 | 0.660 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 325 | 0.600 |
Why?
|
Epigenesis, Genetic | 9 | 2022 | 3639 | 0.580 |
Why?
|
Paraffin Embedding | 5 | 2020 | 299 | 0.580 |
Why?
|
Tissue Fixation | 4 | 2020 | 241 | 0.550 |
Why?
|
Colorectal Neoplasms | 11 | 2021 | 6754 | 0.510 |
Why?
|
Histone Code | 1 | 2016 | 163 | 0.510 |
Why?
|
Receptors, Androgen | 6 | 2022 | 1057 | 0.500 |
Why?
|
Rectal Neoplasms | 3 | 2012 | 1195 | 0.480 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1376 | 0.440 |
Why?
|
Formaldehyde | 4 | 2023 | 353 | 0.420 |
Why?
|
Histones | 7 | 2022 | 2597 | 0.360 |
Why?
|
Neoplasms | 10 | 2022 | 21596 | 0.350 |
Why?
|
Prostatic Neoplasms | 6 | 2022 | 11039 | 0.350 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2022 | 2229 | 0.330 |
Why?
|
Drug Resistance, Neoplasm | 8 | 2022 | 5163 | 0.300 |
Why?
|
Adenocarcinoma | 6 | 2021 | 6347 | 0.280 |
Why?
|
Proto-Oncogene Proteins | 4 | 2022 | 4553 | 0.270 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 3 | 2021 | 170 | 0.260 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2016 | 892 | 0.250 |
Why?
|
ras Proteins | 1 | 2009 | 1060 | 0.240 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 384 | 0.240 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2940 | 0.240 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2022 | 794 | 0.230 |
Why?
|
Lipid Peroxidation | 1 | 2004 | 270 | 0.230 |
Why?
|
Cell Line, Tumor | 16 | 2022 | 16665 | 0.230 |
Why?
|
RNA, Messenger | 3 | 2016 | 13029 | 0.220 |
Why?
|
Sequence Analysis, DNA | 5 | 2023 | 4801 | 0.220 |
Why?
|
cdc42 GTP-Binding Protein | 2 | 2017 | 194 | 0.210 |
Why?
|
HMGN1 Protein | 2 | 2020 | 27 | 0.210 |
Why?
|
Fixatives | 2 | 2020 | 94 | 0.210 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2022 | 798 | 0.210 |
Why?
|
Colonic Neoplasms | 4 | 2016 | 2542 | 0.200 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5249 | 0.200 |
Why?
|
Lysine | 3 | 2020 | 1008 | 0.190 |
Why?
|
SOXC Transcription Factors | 1 | 2020 | 40 | 0.190 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 185 | 0.190 |
Why?
|
SOX9 Transcription Factor | 1 | 2021 | 146 | 0.190 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 4751 | 0.190 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13019 | 0.190 |
Why?
|
Kaplan-Meier Estimate | 7 | 2020 | 6534 | 0.180 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2021 | 628 | 0.180 |
Why?
|
Sciatic Neuropathy | 1 | 2000 | 74 | 0.180 |
Why?
|
Acetylation | 5 | 2020 | 1085 | 0.180 |
Why?
|
Peptides | 1 | 2012 | 4392 | 0.180 |
Why?
|
Disease-Free Survival | 8 | 2016 | 6891 | 0.170 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3691 | 0.170 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 284 | 0.170 |
Why?
|
Oncogene Proteins | 2 | 2020 | 749 | 0.170 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2021 | 730 | 0.170 |
Why?
|
Carcinoma, Lobular | 2 | 2022 | 484 | 0.170 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 317 | 0.170 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 241 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9185 | 0.170 |
Why?
|
3' Untranslated Regions | 2 | 2021 | 508 | 0.170 |
Why?
|
Mutation | 7 | 2022 | 29717 | 0.160 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 526 | 0.160 |
Why?
|
Prognosis | 18 | 2022 | 29010 | 0.160 |
Why?
|
Cell Transplantation | 1 | 2000 | 477 | 0.160 |
Why?
|
Mice | 19 | 2023 | 81045 | 0.160 |
Why?
|
Tumor Escape | 1 | 2020 | 349 | 0.160 |
Why?
|
Receptors, Erythropoietin | 2 | 2008 | 147 | 0.150 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 1114 | 0.150 |
Why?
|
Choline Kinase | 2 | 2007 | 5 | 0.150 |
Why?
|
Trisomy | 1 | 2018 | 266 | 0.150 |
Why?
|
Antigens, Neoplasm | 2 | 2020 | 1983 | 0.150 |
Why?
|
Coenzyme A Ligases | 1 | 2016 | 43 | 0.150 |
Why?
|
Barrett Esophagus | 1 | 2021 | 494 | 0.150 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2077 | 0.140 |
Why?
|
Humans | 62 | 2023 | 742088 | 0.140 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 450 | 0.140 |
Why?
|
Pyrimidines | 2 | 2021 | 2933 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1820 | 0.140 |
Why?
|
Integrins | 1 | 2020 | 845 | 0.140 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2000 | 604 | 0.140 |
Why?
|
Mice, Inbred NOD | 2 | 2020 | 1875 | 0.140 |
Why?
|
Epigenomics | 4 | 2023 | 902 | 0.140 |
Why?
|
Animals | 25 | 2023 | 168561 | 0.140 |
Why?
|
Hyperalgesia | 1 | 2000 | 502 | 0.140 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2022 | 1101 | 0.140 |
Why?
|
Genome | 2 | 2022 | 1803 | 0.130 |
Why?
|
Signal Transduction | 9 | 2022 | 23387 | 0.130 |
Why?
|
Nuclear Proteins | 4 | 2021 | 5851 | 0.130 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 2011 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2020 | 729 | 0.130 |
Why?
|
Hepatocytes | 1 | 2022 | 1209 | 0.130 |
Why?
|
Prostate | 3 | 2022 | 1764 | 0.130 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 594 | 0.130 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 553 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2023 | 3585 | 0.120 |
Why?
|
Glycosyltransferases | 1 | 2014 | 113 | 0.120 |
Why?
|
Cell Lineage | 2 | 2021 | 2504 | 0.120 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11363 | 0.120 |
Why?
|
Leukemia | 1 | 2022 | 1507 | 0.120 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2014 | 171 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2004 | 3081 | 0.110 |
Why?
|
Binding Sites | 2 | 2019 | 6115 | 0.110 |
Why?
|
Telomere | 1 | 2019 | 909 | 0.110 |
Why?
|
Protein Binding | 3 | 2021 | 9387 | 0.110 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 408 | 0.110 |
Why?
|
Cell Nucleus | 1 | 2022 | 2968 | 0.110 |
Why?
|
Breast Neoplasms | 6 | 2022 | 20774 | 0.110 |
Why?
|
Antineoplastic Agents | 7 | 2021 | 13655 | 0.110 |
Why?
|
Proto-Oncogenes | 1 | 2013 | 321 | 0.110 |
Why?
|
Homeodomain Proteins | 2 | 2019 | 2417 | 0.110 |
Why?
|
Transcription, Genetic | 4 | 2020 | 7721 | 0.100 |
Why?
|
Computational Biology | 2 | 2021 | 3518 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1860 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1899 | 0.100 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2012 | 102 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11472 | 0.100 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6171 | 0.100 |
Why?
|
Protein Processing, Post-Translational | 1 | 2019 | 1989 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1581 | 0.100 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2013 | 338 | 0.100 |
Why?
|
Apoptosis | 4 | 2020 | 9715 | 0.100 |
Why?
|
Stomach Neoplasms | 2 | 2012 | 1327 | 0.100 |
Why?
|
Transfection | 3 | 2012 | 5892 | 0.090 |
Why?
|
Down Syndrome | 1 | 2018 | 880 | 0.090 |
Why?
|
Protein Array Analysis | 1 | 2012 | 411 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4438 | 0.090 |
Why?
|
Cell Differentiation | 3 | 2022 | 11470 | 0.090 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2009 | 44 | 0.090 |
Why?
|
Cell Proliferation | 6 | 2022 | 10472 | 0.090 |
Why?
|
Frozen Sections | 1 | 2010 | 155 | 0.090 |
Why?
|
Trans-Activators | 1 | 2019 | 2924 | 0.090 |
Why?
|
DNA Methylation | 4 | 2022 | 4282 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2016 | 1294 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2915 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4414 | 0.080 |
Why?
|
Endonucleases | 1 | 2012 | 381 | 0.080 |
Why?
|
Male | 25 | 2022 | 349538 | 0.080 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2008 | 19 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3557 | 0.080 |
Why?
|
DNA | 1 | 2023 | 7289 | 0.080 |
Why?
|
Deoxycytidine | 1 | 2012 | 824 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3563 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3920 | 0.080 |
Why?
|
Aged, 80 and over | 11 | 2016 | 57683 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2021 | 704 | 0.080 |
Why?
|
Up-Regulation | 2 | 2018 | 4211 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3381 | 0.070 |
Why?
|
Fluorouracil | 1 | 2012 | 1615 | 0.070 |
Why?
|
Neoplasm Staging | 7 | 2020 | 11001 | 0.070 |
Why?
|
Cell Survival | 4 | 2020 | 5872 | 0.070 |
Why?
|
Nucleosomes | 2 | 2023 | 493 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12242 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2009 | 2938 | 0.070 |
Why?
|
Cisplatin | 2 | 2012 | 1637 | 0.070 |
Why?
|
Clone Cells | 2 | 2020 | 1692 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5655 | 0.070 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2007 | 236 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1887 | 0.070 |
Why?
|
Female | 27 | 2022 | 379592 | 0.070 |
Why?
|
Neoplasm Metastasis | 5 | 2018 | 4839 | 0.070 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2085 | 0.060 |
Why?
|
Cell Cycle Proteins | 3 | 2022 | 3444 | 0.060 |
Why?
|
Organoids | 2 | 2021 | 692 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6096 | 0.060 |
Why?
|
Cell Line | 5 | 2020 | 15994 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2021 | 1366 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 2021 | 6382 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2374 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3497 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 15494 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2021 | 2948 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4823 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9274 | 0.060 |
Why?
|
Neoadjuvant Therapy | 2 | 2012 | 2721 | 0.060 |
Why?
|
Aged | 15 | 2018 | 162944 | 0.060 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6313 | 0.060 |
Why?
|
RNA Interference | 3 | 2021 | 2890 | 0.060 |
Why?
|
Erythropoietin | 1 | 2007 | 724 | 0.050 |
Why?
|
Survival Analysis | 2 | 2016 | 10248 | 0.050 |
Why?
|
Middle Aged | 16 | 2018 | 213127 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1683 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 21821 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2021 | 27 | 0.050 |
Why?
|
Adult | 14 | 2022 | 213712 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2022 | 77098 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 318 | 0.050 |
Why?
|
HT29 Cells | 1 | 2021 | 200 | 0.050 |
Why?
|
Deoxycytosine Nucleotides | 1 | 2020 | 14 | 0.050 |
Why?
|
Genes, APC | 1 | 2021 | 159 | 0.050 |
Why?
|
Genes, myc | 1 | 2022 | 399 | 0.050 |
Why?
|
Histone Demethylases | 1 | 2023 | 320 | 0.050 |
Why?
|
Neurons | 1 | 2000 | 9325 | 0.050 |
Why?
|
RNA | 2 | 2022 | 2747 | 0.050 |
Why?
|
Genes, cdc | 1 | 2020 | 116 | 0.050 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2020 | 56 | 0.050 |
Why?
|
NF-kappa B | 1 | 2009 | 2500 | 0.050 |
Why?
|
Tubulin | 1 | 2004 | 695 | 0.050 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2020 | 104 | 0.050 |
Why?
|
Metaplasia | 1 | 2021 | 313 | 0.050 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 112 | 0.050 |
Why?
|
Mediator Complex | 1 | 2020 | 109 | 0.050 |
Why?
|
Phenylenediamines | 1 | 2020 | 90 | 0.040 |
Why?
|
Cyclin E | 1 | 2020 | 172 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2009 | 5171 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 289 | 0.040 |
Why?
|
Disease Progression | 4 | 2021 | 13256 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2020 | 168 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 408 | 0.040 |
Why?
|
Nitriles | 2 | 2018 | 952 | 0.040 |
Why?
|
Ligation | 1 | 2000 | 453 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2014 | 3471 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12797 | 0.040 |
Why?
|
Lymph Nodes | 3 | 2020 | 3465 | 0.040 |
Why?
|
Gene Library | 1 | 2021 | 1076 | 0.040 |
Why?
|
Acrylamides | 1 | 2020 | 252 | 0.040 |
Why?
|
Blotting, Western | 3 | 2013 | 5180 | 0.040 |
Why?
|
Physical Stimulation | 1 | 2000 | 525 | 0.040 |
Why?
|
Chemotaxis | 1 | 2021 | 607 | 0.040 |
Why?
|
Introns | 1 | 2021 | 991 | 0.040 |
Why?
|
Phenotype | 3 | 2021 | 16331 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 504 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 337 | 0.040 |
Why?
|
Immune Evasion | 1 | 2021 | 360 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 336 | 0.040 |
Why?
|
Tamoxifen | 1 | 2022 | 980 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2015 | 62966 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2000 | 517 | 0.040 |
Why?
|
Interferons | 1 | 2021 | 704 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2021 | 1802 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1791 | 0.040 |
Why?
|
Genetic Testing | 1 | 2010 | 3439 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 867 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 535 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 954 | 0.040 |
Why?
|
Phenylthiohydantoin | 1 | 2018 | 192 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4249 | 0.040 |
Why?
|
Cold Temperature | 1 | 2000 | 774 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 987 | 0.040 |
Why?
|
Workflow | 1 | 2021 | 846 | 0.040 |
Why?
|
Oncogenes | 1 | 2022 | 1263 | 0.040 |
Why?
|
Antioxidants | 1 | 2004 | 1659 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2020 | 1099 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 861 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1782 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 537 | 0.030 |
Why?
|
Gene Dosage | 1 | 2020 | 1251 | 0.030 |
Why?
|
1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2015 | 10 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1905 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1727 | 0.030 |
Why?
|
Muscles | 1 | 2020 | 1617 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2008 | 1799 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1119 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 789 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1038 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14554 | 0.030 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2015 | 86 | 0.030 |
Why?
|
Regression Analysis | 2 | 2015 | 6452 | 0.030 |
Why?
|
Mitochondria | 2 | 2005 | 3520 | 0.030 |
Why?
|
Cell Membrane | 1 | 2004 | 3744 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12773 | 0.030 |
Why?
|
Antigens | 1 | 2020 | 1462 | 0.030 |
Why?
|
DNA Damage | 1 | 2004 | 2423 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 907 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9639 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2186 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2023 | 4742 | 0.030 |
Why?
|
Hot Temperature | 1 | 2000 | 1355 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2005 | 2896 | 0.030 |
Why?
|
rab3 GTP-Binding Proteins | 1 | 2013 | 29 | 0.030 |
Why?
|
Calcium Channels | 1 | 2017 | 621 | 0.030 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 284 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2020 | 2006 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3862 | 0.030 |
Why?
|
Young Adult | 3 | 2016 | 56350 | 0.030 |
Why?
|
Recurrence | 2 | 2015 | 8333 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1940 | 0.030 |
Why?
|
Benzamides | 1 | 2018 | 1378 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4187 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2017 | 1097 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1683 | 0.030 |
Why?
|
Apolipoproteins | 1 | 2014 | 315 | 0.030 |
Why?
|
E-Selectin | 1 | 2014 | 579 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2000 | 1882 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1581 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2751 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2133 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2020 | 4200 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17400 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 2008 | 2906 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 3020 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18006 | 0.020 |
Why?
|
Mice, Nude | 2 | 2007 | 3689 | 0.020 |
Why?
|
Etoposide | 1 | 2012 | 637 | 0.020 |
Why?
|
Pain Measurement | 1 | 2000 | 3418 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2723 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2014 | 676 | 0.020 |
Why?
|
Vincristine | 1 | 2012 | 1036 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3587 | 0.020 |
Why?
|
Graft Survival | 1 | 2000 | 3733 | 0.020 |
Why?
|
Chromones | 1 | 2009 | 154 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 5519 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 578 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9735 | 0.020 |
Why?
|
Carboplatin | 1 | 2012 | 799 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3564 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2713 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1707 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3493 | 0.020 |
Why?
|
Neoplastic Processes | 1 | 2007 | 35 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2010 | 376 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12344 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2009 | 2502 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4420 | 0.020 |
Why?
|
Cadherins | 1 | 2012 | 906 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 452 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7790 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2020 | 5019 | 0.020 |
Why?
|
beta Catenin | 1 | 2012 | 1058 | 0.020 |
Why?
|
Biological Assay | 1 | 2010 | 652 | 0.020 |
Why?
|
Sulfones | 1 | 2009 | 437 | 0.020 |
Why?
|
Reference Standards | 1 | 2010 | 1020 | 0.020 |
Why?
|
Morpholines | 1 | 2009 | 561 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19862 | 0.020 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2005 | 79 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2008 | 598 | 0.020 |
Why?
|
Doxorubicin | 1 | 2012 | 2215 | 0.020 |
Why?
|
Time Factors | 3 | 2015 | 40054 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4664 | 0.020 |
Why?
|
Chaperonin 60 | 1 | 2005 | 103 | 0.020 |
Why?
|
Proton-Translocating ATPases | 1 | 2005 | 116 | 0.020 |
Why?
|
Colon | 1 | 2013 | 1773 | 0.020 |
Why?
|
Pain | 1 | 2000 | 4961 | 0.020 |
Why?
|
DNA Repair | 1 | 2014 | 2042 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5212 | 0.020 |
Why?
|
Boronic Acids | 1 | 2009 | 965 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7167 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7470 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2005 | 424 | 0.020 |
Why?
|
Models, Biological | 1 | 2020 | 9581 | 0.010 |
Why?
|
Pyruvate Kinase | 1 | 2005 | 189 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7873 | 0.010 |
Why?
|
Rats | 1 | 2000 | 24265 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4328 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 7901 | 0.010 |
Why?
|
Pyrazines | 1 | 2009 | 1231 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1780 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10163 | 0.010 |
Why?
|
Drugs, Investigational | 1 | 2004 | 214 | 0.010 |
Why?
|
Gene Silencing | 1 | 2008 | 1538 | 0.010 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2006 | 602 | 0.010 |
Why?
|
Glycolysis | 1 | 2005 | 825 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 3001 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2006 | 1184 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3612 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12946 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39004 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8436 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3701 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6608 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 5867 | 0.010 |
Why?
|
Forecasting | 1 | 2006 | 2948 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12220 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8621 | 0.010 |
Why?
|
Breast | 1 | 2005 | 1958 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 9941 | 0.010 |
Why?
|
Proteome | 1 | 2005 | 1790 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21719 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10392 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2455 | 0.010 |
Why?
|
Child | 1 | 2022 | 77478 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15056 | 0.010 |
Why?
|
Proteomics | 1 | 2006 | 3618 | 0.010 |
Why?
|
Decision Making | 1 | 2006 | 3869 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 72145 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14720 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 53187 | 0.010 |
Why?
|
Genomics | 1 | 2006 | 5692 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 23320 | 0.010 |
Why?
|